Integra LifeSciences Holdings Corporation IART

IART Company Overview

Integra LifeSciences Holdings Corporation is a U.S.-based medical technology company that develops, manufactures, and markets medical devices, implants, biologics, and surgical instruments used primarily in neurosurgery, wound care, reconstructive surgery, and related specialties. The company operates within the broader healthcare and medical devices industry, serving hospitals, surgical centers, clinicians, and healthcare systems globally. Its principal revenue drivers include neurosurgical products, regenerative tissue technologies, advanced wound care solutions, and surgical instrumentation platforms. Integra has developed a strong position in specialty surgical markets where procedural complexity, clinical outcomes, and surgeon preference create high barriers to entry.

The company traces its origins to 1989 and has expanded through internal product development and acquisitions. Integra evolved from a regenerative medicine-focused business into a diversified surgical and specialty medical technology company through acquisitions such as Codman Neurosurgery assets from Johnson & Johnson and ACell, Inc. The company’s strategic positioning centers on specialized clinical categories, surgeon-focused innovation, and a portfolio spanning both implantable technologies and surgical tools. Public disclosures in SEC filings and company investor materials consistently identify neurosurgery and tissue technologies as core strategic pillars.